All Stories

  1. Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy
  2. AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
  3. Corrigendum to Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection
  4. Alcohol delamination and topical mitomycin-C 0.02% for the treatment of corneal intraepithelial neoplasia
  5. Enhancing Visual Quality: The Impact of Alcohol-Assisted Delamination on Corneal Aberrations in Patients with Central Epithelial Basement Membrane Dystrophy
  6. Safety of intravitreal injections with the mobile laminar airflow device Operio after more than 10.000 injections
  7. Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
  8. Combined Multilayered Amniotic Membrane Graft and Fibrin Glue as a Surgical Management of Limbal Dermoid Cyst
  9. Mobile unidirectional airflow device reduces air contamination in an intravitreal outpatient clean room setting
  10. Optic disc pit maculopathy: Covering or filling technique with human amniotic membrane patch to treat the optic disc pit maculopathy?
  11. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  12. TENAYA and LUCERNE
  13. Predictive Role of Fluorescein Angiography in Retinopathy of Prematurity
  14. Faricimab Treat-and-Extend for Diabetic Macular Edema
  15. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
  16. Combined superficial keratectomy, alcohol delamination and amniotic membrane patch with fibrin glue in Salzmann nodular degeneration
  17. Increasing incidence of contact-lens-related Acanthamoeba keratitis in a tertiary ophthalmology department in an Italian population
  18. Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery
  19. Choroidal vascularity analysis in patients with juvenile idiopathic arthritis without acute uveitis
  20. Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection
  21. Efficacy and Safety of PreserFlo MicroShunt Implantation and Its Effects on Intraocular Inflammation through Laser Flare Photometry
  22. Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line
  23. Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study
  24. New insights on circumscribed choroidal hemangioma: “bench to bedside”
  25. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
  26. Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series
  27. Choroidal vascularity profile in diabetic eyes using wide field optical coherence tomography
  28. Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy
  29. Primary small gauge pars plana vitrectomy and silicone oil endotamponade for endophthalmitis after cataract surgery: Clinical and OCT findings
  30. Biologic therapies for juvenile idiopathic arthritis-associated uveitis
  31. Improvement of retinal OCT angiograms by Sampling Kantorovich algorithm in the assessment of retinal and choroidal perfusion
  32. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity
  33. Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  34. Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
  35. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  36. In-vivo visualization of the photoreceptors using Spectralis High Magnification Module imaging in central serous chorioretinopathy
  37. Choroidal vasculature analysis in MEK inhibitor-associated retinopathy
  38. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
  39. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
  40. New trends in intravitreal anti-VEGF therapy for ROP
  41. Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study
  42. Wide-field optical coherence tomography imaging in diabetic retinopathy
  43. Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms
  44. Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
  45. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  46. Corneal and Epithelial Thickness Mapping: Comparison of Enhanced Spectral-Domain- and Spectral-Domain-Optical Coherence Tomography
  47. The choroidal rupture: current concepts and insights
  48. Real‐world outcomes of anti‐VEGF therapy in treatment‐naïve neovascular age‐related macular degeneration diagnosed on OCT angiography: the REVEAL study
  49. Comparison of two different scleral fixation techniques of posterior chamber Carlevale lens
  50. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  51. Intraretinal, sub-retinal, and sub-retinal pigmented epithelium fluid in non-exudative age-related macular degeneration: follow-up with OCT imaging
  52. Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
  53. Sildenafil in Ophthalmology: An update
  54. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders
  55. Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography
  56. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  57. Drusen ooze: Predictor for progression of dry age-related macular degeneration
  58. Functional expression and localisation of HOPS/TMUB1 in mouse lens
  59. A novel approach for scleral fixation using Carlevale lens
  60. Central serous chorioretinopathy imaging biomarkers
  61. Wide-field choroidal vascular analysis in central serous chorioretinopathy
  62. OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study
  63. Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi—the SON study
  64. Xen Gel Stent as a minimally invasive option for intraocular pressure control after DSAEK: A case study
  65. Factors predicting normal visual acuity following anatomically successful macular hole surgery
  66. Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence
  67. Epi-off-lenticule-on corneal collagen cross-linking in thin keratoconic corneas
  68. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial
  69. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study
  70. Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  71. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects
  72. Wide-field individual retinal layer thickness in healthy eyes
  73. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  74. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  75. Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy
  76. Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study
  77. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  78. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study
  79. Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery
  80. Efficacy of topical microemulsion of fatty acids of the ω-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus
  81. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
  82. The Effectiveness of 0.6% Povidone Iodine Eye Drops in Reducing the Conjunctival Bacterial Load and Needle Contamination in Patients Undergoing Anti-VEGF Intravitreal Injection: A Prospective, Randomized Study
  83. Safety of 6000 intravitreal dexamethasone implants
  84. Efficacy of Three Different Prophylactic Treatments for Postoperative Nausea and Vomiting after Vitrectomy: A Randomized Clinical Trial
  85. Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs
  86. New insight on choroidal vasculature: multimodal morphofunctional approach
  87. Wide-field choroidal thickness profile in healthy eyes
  88. Correlation of central and peripheral keratometric parameters after corneal collagen cross-linking in keratoconus patients
  89. Intraocular lens dislocation: a novel in-situ scleral refixation technique using a 25 Gauge trocar in the anterior chamber
  90. Retinal Vascular Reactivity in Central Serous Chorioretinopathy
  91. Wide-field Choroidal Vascularity in Healthy Eyes
  92. New Insights On Ocular Sarcoidosis: An Optical Coherence Tomography Angiography Study
  93. Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
  94. Corneal incision width after lens implantation: Comparing delivery systems
  95. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
  96. Confocal scanning laser microscopy in patients with postoperative endophthalmitis
  97. Optical coherence tomography angiography in age-related macular degeneration: The game changer
  98. Binocular cyclotorsion in superior vestibular neuritis
  99. Microbubble technique in failed deep anterior lamellar keratoplasty: 2-year outcomes
  100. Optical Coherence Tomography Angiography in Healthy Subjects and Diabetic Patients
  101. Reply to Comment on: ‘Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine’
  102. Bimanual microincision cataract surgery with implantation of the new Incise® MJ14 intraocular lens through a 1.4 mm incision
  103. Visual pathway involvement in multiple sclerosis: Look straight in the eyes
  104. Tear Film Stability in Sjögren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops
  105. Ocular and oto-syphilis: not a thing of the past
  106. Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach
  107. Red reflex screening highly sensitive for anterior segment abnormalities
  108. A recent finding in Fuchs uveitis: choroidal thinning
  109. Depth-Resolved Imaging of Papillary Vitreoretinal Neovascularization
  110. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine
  111. Aqueous Humor Antimicrobial Activity: In Vitro Analysis after Topical 0.5% Chloramphenicol Application
  112. Retinal Microvasculature in Nonproliferative Diabetic Retinopathy: Automated Quantitative Optical Coherence Tomography Angiography Assessment
  113. Associations of Alzheimer rsquo s disease with macular degeneration
  114. Optical Coherence Tomography Angiography in Macular Edema
  115. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma
  116. Red reflex examination in neonates: evaluation of 3 years of screening
  117. Outer Retinal and Choroidal Evaluation in Multiple Evanescent White Dot Syndrome (MEWDS): An Enhanced Depth Imaging Optical Coherence Tomography Study
  118. Diabetic maculopathy: Confrontation of FA and OCT‐A findings
  119. Deep inside Multifocal Choroiditis: an Optical Coherence Tomography Angiography approach
  120. Full-thickness choroidal thinning as a feature of Fuchs Uveitis Syndrome: quantitative evaluation of the choroid by Enhanced Depth Imaging Optical Coherence Tomography in a cohort of consecutive patients
  121. Automated Quantitative Analysis of Retinal Microvasculature in Normal Eyes on Optical Coherence Tomography Angiography
  122. Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization
  123. ‘False-friend’ images on optical coherence tomography angiography: early choroidal neovascularization or artefact?
  124. A case of unilateral circumscribed posterior keratoconus evaluated by three different imaging tools: optical coherence tomography, videokeratography, and Scheimpflug corneal tomography
  125. Hypotonic Maculopathy Secondary to Scleral Defect in Atypical Retinochoroidal Coloboma
  126. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up
  127. Endoscopic dacryocystorhinostomy with and without silicone intubation: 4 years retrospective study
  128. Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage
  129. Sliding Keratoplasty Followed by Transepithelial Iontophoresis Collagen Cross-linking for Pellucid Marginal Degeneration
  130. Canaloplasty: Current Value in the Management of Glaucoma
  131. Optical Coherence Tomography Angiography of a Choroidal Neovascularization in Adult Onset Foveomacular Vitelliform Dystrophy: Pearls and Pitfalls
  132. Dexamethasone Disodium Phosphate Penetration Into the Human Aqueous Humor After Topical Application
  133. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  134. Anterior Corneal Surface Irregularity after Descemet-Stripping Endothelial Keratoplasty for Bullous Keratopathy
  135. Reasons for Visits to an Emergency Center and Hemostatic Alterations in Patients with Recurrent Spontaneous Subconjunctival Hemorrhage
  136. A superfusion apparatus for ex vivo human eye irritation investigations
  137. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature
  138. Chloramphenicol, reaches effective concentrations against several germs.
  139. Repeatability of Retinal Macular Thickness Measurements in Healthy Subjects and Diabetic Patients with Clinically Significant Macular Edema: Evaluation of the Follow-Up System of Spectralis Optical Coherence Tomography
  140. Author's Replay: Correcting timolol prescribing in glaucoma management
  141. Long-term analysis of IOL stability of the Lewis technique for scleral fixation
  142. Optical Coherence Tomography Angiography during Follow-Up: Qualitative and Quantitative Analysis of Mixed Type I and II Choroidal Neovascularization after Vascular Endothelial Growth Factor Trap Therapy
  143. Repeatability of Retinal Macular Thickness Measurements in Patients with Clinically Significant Macular Edema Using Two Different Scanning Protocols of Spectralis Optical Coherence Tomography
  144. Posterior Corneal Surface Stability after Femtosecond Laser-Assisted Keratomileusis
  145. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
  146. Post-operative endophthalmitis caused by Acremonium falciforme with orbital and extra-orbital involvement following combined cataract and glaucoma surgery: a case report
  147. Influence of Pseudophakic Lens Capsule Opacification on Spectral Domain and Time Domain Optical Coherence Tomography Image Quality
  148. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography
  149. Timolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery
  150. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study
  151. Correction to: Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  152. Ocular penetration of topical antibiotics: study on the penetration of chloramphenicol, tobramycin and netilmicin into the anterior chamber after topical administration
  153. Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  154. Survey on retinopathy of prematurity (ROP) in Italy
  155. Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study
  156. Penetration of Prulifloxacin in human aqueous humour following oral administration
  157. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
  158. Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study
  159. Simultaneous Descemet Stripping Automated Endothelial Keratoplasty and Aphakic Iris-Fixated Intraocular Lens Implantation: A Case Series
  160. Study of Ethane Level in Exhaled Breath in Patients with Age-Related Macular Degeneration: Preliminary Study
  161. RETINAL TOXICITY OF INTRAVITREAL GENISTEIN IN A RABBIT MODEL
  162. Rituximab Treatment for Persistent Scleritis Associated with Rheumatoid Arthritis
  163. Study of alpha-lipoic acid penetration in the human aqueous after topical administration
  164. Macular Thickness Measured by Optical Coherence Tomography in a Healthy Population Before and After Uncomplicated Cataract Phacoemulsification Surgery
  165. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography
  166. Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
  167. Retinal Astrocytic Hamartoma with Associated Macular Edema: Report of Spontaneous Resolution of Macular Edema as a Result of Increasing Hamartoma Calcification
  168. Limbal anaesthesia versus topical anaesthesia for clear corneal phacoemulsification
  169. In response to comments on limbal anaesthesia for clear cornea phacoemulsification
  170. Efficacy and safety of limbal anaesthesia for clear cornea phacoemulsification
  171. Longterm results of one-site phacotrabeculectomy
  172. Post-transplant complications. cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation. Aristei C,* Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P. Bone Marrow Tr...
  173. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation
  174. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
  175. Cataracts in patients submitted to bone marrow transplantation conditioned with total body irradiation
  176. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study
  177. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
  178. Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study
  179. Nutritional intake of 2868 IDDM patients from 30 centres in Europe
  180. Cardiovascular Disease and Its Risk Factors in IDDM in Europe
  181. The Relationship Between Pregnancy and Long‐term Maternal Complications in the EURODIAB IDDM Complications Study
  182. The Relationship Between Smoking and Microvascular Complications in the EURODIAB IDDM Complications Study
  183. Study of functionality of cochlear outer hair cells in patients with retinitis pigmentosa
  184. Evaluation of functionality of cochlear outer hair cells in patients with retinitis pigmentosa and in their relatives
  185. Evoked otoacoustic emissions behaviour in retinitis pigmentosa
  186. Influences of birthweight upon brainstem maturation as reflected by auditory brainstem response (ABR) evaluation